Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Anna Del Llano

Business Development Manager

Lausanne, Switzerland - July 22, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ELTA 90...

Partnerships

Elta90 to distribute VarSome Clinical in Serbia, Montenegro, Bosnia & Herzegovina

By Anna Del Llano on July 22, 2020

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Gene fusion detection: Liquid biopsies and classification of co-mutations

Company News listing page

Categories

Stay up to date

Anna Del Llano

Elta90 to distribute VarSome Clinical in Serbia, Montenegro, Bosnia & Herzegovina